Akari Therapeutics (AKTX) Profit After Tax Growth (1y) (2015 - 2026)
Akari Therapeutics (AKTX) Profit After Tax Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 66.06% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 17.05% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -129.68% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -290.15% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -632.44% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290.15% |
| Dec 31, 2025 | 96.22% |
| Sep 30, 2025 | -121.07% |
| Jun 30, 2025 | 74.93% |
| Mar 31, 2025 | 33.44% |
| Dec 31, 2024 | -3,283.11% |
| Sep 30, 2024 | -0.84% |
| Jun 30, 2024 | -88.95% |
| Mar 31, 2024 | -656.04% |
| Dec 31, 2020 | 13.03% |
| Sep 30, 2020 | 131.70% |
| Jun 30, 2020 | -25.09% |
| Mar 31, 2020 | -1,908.14% |
| Mar 31, 2016 | -75.94% |
| Dec 31, 2015 | 681.09% |
| Sep 30, 2015 | -21,741.93% |
| Jun 30, 2015 | 25.03% |
| Mar 31, 2015 | 2.48% |